3-substituted oxindole β3 agonists

The present invention relates to a β3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sall, Daniel Jon, Bastian, Jolie Anne, Jesudason, Cynthia Darshini, Finley, Don Richard, Stevens, Freddie Craig, Rocco, Vincent Patrick, Spinazze, Patrick Gianpietro, He, John Xiaoqiang, Werner, John Arnold, Trankle, William George, Ratz, Andrew Michael, Schotten, Theo, Reuhter, Gerd
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a β3 adrenergic receptor agonist of formula I: or a pharmaceutical salt thereof; which is capable of increasing lipolysis and energy expenditure in cells and, therefore, is useful for treating Type 2 diabetes and/or obesity.